Pharmacodynamic Potential of Sub-Gingivally Delivered Lovastatin in The Treatment of Patients with Chronic Localized Moderate Periodontitis: A Longitudinal Study
DOI:
https://doi.org/10.3329/bjms.v24i2.81529Keywords:
beneath the gums, subgingival, local drug delivery, mouth and tooth diseases, chronic periodontitis, effectiveness, therapeutic intervention, a fungal metabolite, lovastatinAbstract
INTRODUCTION Periodontitis is an inflammatory disease caused by specific bacteria that leads to the progressive destruction of toothsupporting tissue. Treatment often includes non-surgical therapy, but antimicrobials may be needed to target bacteria. However, antimicrobial resistance can occur. Statins, particularly lovastatin, have shown promise in reducing inflammation and promoting bone formation in periodontitis treatment. Methods This study included 62 patients (12 males, 50 females) with chronic localized periodontitis aged 29-41. Patients were randomly divided into two groups: one treated with lovastatin gel (experiment group) and the other with a placebo (control group). After baseline measurements, subgingival scaling and gel application were performed. Data was analyzed using SPSS software (IBM SPSS Statistics for Windows, Version 22.0.Armonk, NY: IBM Corp.). Results This longitudinal study evaluated the efficacy of subgingival lovastatin in treating chronic localized moderate periodontitis. The study included 62 patients with no significant baseline differences. Significant improvements were observed in the lovastatin-treated experimental group for sulcus bleeding, pocket probing depth, clinical attachment, and bone fill (93.5% vs. 29% in the control group) Conclusion The study concludes that lovastatin’s local delivery adjunct to scaling and root planning reduces bleeding pocket depth and enhances clinical attachment and bone growth. Long-term, more extensive studies are needed to assess its full benefits.
Bangladesh Journal of Medical Science Vol. 24 No. 02 April’25 Page : 413-422
Downloads
212
267
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hejal K Bhamtikar, Bindu R Nayar, Lalbahadur L. Sadhu , Aayushi Gupta , Mainul Haque

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.